Here's Why Quidel Stock Is Soaring Today
Shares of Quidel (NASDAQ: QDEL), a diagnostics company that specializes in rapid testing for a variety of diseases, were on the rise following good news from the FDA. The company's point-of-care SARS-CoV-2 test received an emergency use authorization (EUA) on Saturday, and as a result, the stock was up 31.1% as of 3:18 p.m. EDT Monday.
The Food and Drug Administration has handed out a lot of EUAs for new coronavirus tests recently, but Quidel's stands out as the only antigen-based test. The Sofia 2 SARS-CoV-2 Antigen FIA looks for specific pieces of the novel coronavirus instead of the antibodies our immune systems generate in response to those antigens.
Image source: Getty Images.
Source Fool.com
